AMA Update for Aug. 31, 2023: The latest FDA naloxone approvals and Overdose Awareness Day with Bobby Mukkamala, MD
·
13 Min Read

The latest FDA naloxone approvals and Overdose Awareness Day with Bobby Mukkamala, MD

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about the current state of the overdose epidemic.

series
Behavioral Health
AMA Update
Physician working on an opioid prescription on the computer.
·
6 Min Read

What is the MATE Act?

The MATE Act requires health care professionals who prescribe controlled substances to complete 8 hours of training for treating and managing patients with substance use disorder.

series
Behavioral Health
Health Care Definitions
·
2 Min Read

AMA applauds FDA's approval of second OTC naloxone product

The AMA has long advocated for improved access to OTC naloxone as the deadly drug overdose epidemic continues to devastate communities.

Press Releases
Pregnant patient having blood pressure measured
·
4 Min Read

Don’t criminalize pregnant patients with substance-use disorders

An Ohio mom was prosecuted after disclosing her illicit drug use upon giving birth. Learn why an appeals court was right to overturn her conviction.

Judicial Advocacy
Doctor using stethoscope on a pregnant patient
·
5 Min Read

Boosting treatment for incarcerated pregnant patients with SUDs

Pregnant people with a substance use disorder have the same right to treatment as any other person with an SUD. Learn more.

Behavioral Health
2023 Annual Meeting delegates from Kansas and Missouri
·
4 Min Read

Put naloxone in schools so it can save lives

Opioid overdose-reversing drugs such as naloxone save lives. They should be available in educational settings and public areas, the AMA says.

Behavioral Health
·
4 Min Read

AMA adopts new policies on substance use during second day of Annual Meeting

Policies address opioid crisis and medicinal use of psychedelics.

Press Releases
AMA in Action: Ending the overdose epidemic
UPDATED
·
4 Min Read

Advocacy in action: Ending the overdose epidemic

Science, evidence and compassion must guide patient care and policy change to end the drug-overdose epidemic.

Behavioral Health
Narcan nasal spray
·
4 Min Read

Narcan lands OTC approval: What it means for patients, doctors

The drug’s manufacturer and retailers must help ensure the lifesaving opioid overdose-reversal medication is widely available at an affordable price. 

Behavioral Health